In addition, some recent observations (Wang et al. 2021), coupled with earlier work (Okamoto et al. 2015, 2017), suggest that GCGR blockade can also promote recovery of functional beta-cell mass, with obvious additional benefits for diabetes. This evidence concerns the gene GCGR and diabetes mellitus.